Real-World Persistence of Long-Acting Cabotegravir for HIV Pre-Exposure Prophylaxis in the United States: Results From the PrEPFACTS Study Using Healthcare Administrative Claims Data

Conference Reports for NATAP

IDSA
ID Week 2026
October 21-24
Washington, DC


Real-World Persistence of Long-Acting Cabotegravir for HIV Pre-Exposure Prophylaxis in the United States: Results From the PrEPFACTS Study Using Healthcare Administrative Claims Data

	IDSA 2026 October 21-24 Wash DC